Biotechnology Value Fund L P - Jun 30, 2025 SCHEDULE 13G/A Report for IMMUNIC, INC. Common Stock, $0.0001 par value (IMUX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
IMMUNIC, INC. Common Stock, $0.0001 par value
Symbol
IMUX
Shares outstanding
97.9M shares
Disclosed Ownership
9.79M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 04:02 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 6.4% 6.27M 0 6.27M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 6.4% 6.27M 0 6.27M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3.2% 3.03M 0 3.03M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3.2% 3.03M 0 3.03M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.3% 315K 0 315K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.3% 315K 0 315K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.5% 9.3M 0 9.3M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.99% 9.79M 0 9.79M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.99% 9.79M 0 9.79M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.99% 9.79M 0 9.79M /s/ Mark N. Lampert Mark N. Lampert